Article citationsMore>>

R. Rosell, R. Gervais, A. Vergnenegre, et al., “Erlotinib versus Chemotherapy (CT) in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients (p) with Epidermal Growth Factor Receptor (EGFR) Mutations: Interim Results of the European Erlotinib versus Chemotherapy (EURTAC) Phase III Randomized Trial,” Journal of Clinical Oncology, Vol. 29, 2011, Abstract 7503.

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top